MassDevice

Medtronic launches new guidewire to support TAVR procedures

Medtronic (NYSE: MDT) today announced the launch of its Stedi extra support guidewire for use with its Evolut TAVR platform.
MassDevice

Medtronic inks AI-based TAVR partnership with DASI Simulations

The companies agreed to enhance access to technology from DASI, a leader in AI-driven predictive modeling and digital twin ...
Tyler Morning Telegraph

Medtronic Evolut™ TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients

GALWAY, Ireland and CHICAGO, March 30, 2025 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced late-breaking data on five-year outcomes from the Evolut ...
Business Insider

Medtronic releases two-year results of SMART trial for TAVR

Medtronic (MDT) released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN, SMART, Trial, the largest international head-to-head comparative trial of transfemoral transcatheter ...

Corcym, CardioPrecision set sights on robotic heart valve replacement

The companies have teamed to develop an alternative to TAVR that combines the benefits of a less-invasive procedure with the ...
Business Insider

Medtronic Evolut TAVR System Receives Updated U.S. Labeling Revising Precaution for Treatment of Low-Risk Patients with Bicuspid Aortic Stenosis

Revised Commercial Labeling Broadens Patient Population Who May be Candidates for Transcatheter Aortic Valve Replacement (TAVR) DUBLIN, Aug. 21, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the ...
Nasdaq

Medtronic's (MDT) Newest Evolut TAVR System Gets FDA Approval

Medtronic plc MDT recently secured the FDA’s approval for the Evolut FX+ transcatheter aortic valve replacement (TAVR) system for the treatment of symptomatic severe aortic stenosis. The latest Evolut ...
Nasdaq

Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis

DUBLIN, March 27, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the United States Food and Drug Administration (FDA) has approved the ...
FiercePharma

Medtronic backs push to activate heart valve disease patients as TAVR marketing heats up

Medtronic is pumping up its activation of heart valve disease patients. The company has partnered with an advocacy group for heart valve disease, Heart-Valve-Surgery.com, to create a digital platform ...
ksn.com

Medtronic Evolut™ TAVR platform outperforms surgery with sustained valve performance for low-risk patients at four years

TCT 2023: Medtronic adds to the body of evidence for Evolut TAVR with late-breaking clinical trial data from the Evolut Low Risk Trial DUBLIN and SAN FRANCISCO, Oct. 24, 2023 /PRNewswire/ -- Medtronic ...